In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2.
Shang W, Dai W, Yao C, Xu L, Tao X, Su H, Li J, Xie X, Xu Y, Hu M, Xie D, Jiang H, Zhang L, Liu H.
Shang W, et al. Among authors: xu l, xu y.
Antiviral Res. 2022 Dec;208:105450. doi: 10.1016/j.antiviral.2022.105450. Epub 2022 Oct 29.
Antiviral Res. 2022.
PMID: 36354082
Free PMC article.